Way 2 wealth creation

*Some people never invested in Equity for last 38 years because..*

1982 - Worst recession in 40 years, debt crisis.
1983 - Market hits record - "Market too high".
1984 - Record U.S. Federal deficits.
1985 - Economic growth slows.
1986 - Dow nears 2000 - "Market too high"
1987 - The Crash -Black Monday.
1988 - Fear of Recession.
1989 - Junk Bond collapse.
1990 - Gulf War, worst market decline in 16 years.
1991 - Recession - "Market too high"
1992 - Elections, market flat.
1993 - Businesses continue restructuring.
1994 - Interest rates are going up.
1995 - The market is too high.
1996 - Fear of Inflation.
1997 - Irrational Exuberance.
1998 - Asia Crisis.
1999 - Y2K.
2000 - Technology Correction.
2001 - Recession, World Trade Center Attack.
2002 - Corporate Accounting Scandals.
2003 - War in Iraq.
2004 - U.S. has massive trade & budget deficits.
2005 - Record oil & gas prices.
2006 - Housing bubble bursts.
2007 - Sub-prime mortgage crisis.
2008 - Banking & Credit crisis.
2009 - Recession - "Credit Crunch"
2010 - Sovereign debt crisis.
2011 - Eurozone crisis.
2012 - U.S. fiscal cliff.
2013 - Federal Reserve to "taper"
stimulus.
2014 - Oil prices plunge.
2015 - Chinese stock market sell-off.
2016 - Brexit, U.S. presidential election.
2017 - Stocks at record highs, Bitcoin mania.
2018 - Trade Wars, rising interest rates.
2019 - India GDP at 5 %

Some will always find why not to invest but no one can stop the Market in long run.

*We tend to agree more on any bearish argument.*

*Remember -*

_*"One can create Money by investing in Bull Market but one can create Fortune by investing in Bear Market*"_.

[05/04, 9:27 AM] Way2wealth: Market view: Nifty finds support around 11,559, while 11,663 will act as resistance. Bank Nifty finds support around 29,800, while 30,250 will act as resistance on the upside.
[05/04, 9:28 AM] Way2wealth: Opening Bell: Gainers: Titan (+2%), Cipla, Zee (+1%). Losers: HCL Tech, Maruti (-1%).

Titan's sales increased 21%, and Jewellery segment rose 22% for FY19, in-line with expectations. The company said it is targeting growth of 20% for 2019-20 despite muted outlook for the economy.

Polycab India IPO opens today, price band at Rs533-538 per share open for sale. Offer closes on April 9.

Godrej Properties adds a new residential project in Navi Mumbai. The company increased its equity stake in Wonder Space Properties Private Limited from 25.1% to 96.03% by acquiring equity shares from Shubh Properties Cooperatief U.A.

Jet Airways (India) lenders said they would invite bids for selling the stake in the airline on April 6 as part of a time-bound resolution plan.

Cipla received Establishment Inspection Report on its Goa manufacturing plant by the USFDA. The inspection took place between January 21-28.

Bandhan Bank-Gruh Finance deal filed their respective application for the scheme of amalgamation to the NCLT.
[05/04, 9:28 AM] Way2wealth: Macquarie maintained ‘Outperform’ on Titan with a TP of Rs1,186.

Implied Jewellery segment revenue growth in the March quarter is 18%.
Store addition to adding meaningful growth to the overall segment.
Believe 2019-20 revenue guidance of 20% is the most important takeaway.
Morgan Stanley initiated ‘Equal-weight’ on Odisha Cement with a TP of Rs1,176.

Corporate restructuring is medium-term positive. Well-positioned to deliver strong volume growth.
Net debt to remain stable; Valuations in-line.
JPMorgan maintained ‘Overweight’ on Titan; hiked a TP to Rs1,200 from Rs1,125.

In-line Q4 update; market share gain led momentum continues.
FY20 revenue growth guidance of 20% encouraging.
Expect revenue and net profit to grow at a compounded annual growth rate of 17% and 22% respectively over FY19-21.
Macquarie initiated ‘Outperform’ on Jyothy Lab with a TP of Rs250.

Like a diverse product portfolio with a presence in mainstay categories.
Differentiated product positioning, new product launches and investments in key brands leading to market share gains.
Expect net profit CAGR of 21% and 220bps increase in RoE in the next two years.
Morgan Stanley maintained ‘Overweight’ on Titan with a TP of Rs1,250.

Broad-based growth; Strong end to 2018-19. Q4 – jewellery segment to report strong revenues.
Next stock catalyst is operating margin expansion, which may be greater than the market expects.
Jefferies on City Gas Distributors:

Greater than expected price hike can help in higher margins.
Expect higher margin expansion for MGL and IGL if rupee stays near spot levels.
CNG is still much cheaper than petrol and diesel leaving ample headroom to drive volume growth.
Source: Media reports
[05/04, 9:29 AM] Way2wealth: Positional Call - United Breweries | Buy between Rs1418-1426 | Stoploss Rs1409 | Target Rs1448 | (Holding period 1 - 7 Days).

Stock Future - Hindalco | Buy at Rs211.5-212.5 | Stoploss Rs207.75 | Target Rs216.6-217 | (Hold till Expiry).

[29/03, 07:11] My Office: Axis Bank, India’s third-largest private sector bank, is likely to register 85% earnings CAGR over FY18-20E, driven by NII growth and sharp decline in LLP; valuing at 2.6x FY20E P/BV.
Revenue and operating profit should see stronger growth of 19% and 20% CAGR, respectively, over FY19-20E. It is expected to register 17% loan book CAGR over FY18-20E on strong retail segment growth. The bank is well capitalised to pursue growth opportunities without needing excess capital for the next 2 years. The bank's focus on high-rated corporate accounts and reduction in watchlist (1.8% of advances) will strengthen its asset quality. Credit costs are likely to remain elevated in H1FY19E, normalize in H2FY19E, and decline in FY20E, driving significant improvement in profitability. We expect recovery in ROA and ROE of 90bps to 1.4% and 970bps to 15.4%, respectively, over FY18-20E. The bank’s NII is expected to grow at 21.7% CAGR over FY18-20E and NIM to stabilize at 3.6% by FY20E. The stock is currently trading at 2.34x FY20E P/BV.



Axis Bank’s loan mix, as of Q3FY19, consisted of corporate, retail segment and SMEs contributing ~38%, ~49% and ~13%, respectively. For Q3FY19, Axis Bank’s loan book stood at ~Rs4.75 lakh cr; GNPA was at 5.75%; NNPA was at 2.36%; net interest margin was 3.47% and capital adequacy ratio was at 16.4%.
[29/03, 09:23] My Office: Market view: Nifty finds support at 11,452, while 11,650 will act as resistance. Bank Nifty finds support around 30,200, while 30,750 will act as resistance.
[29/03, 09:23] My Office: Opening Bell: Gainers: NTPC, Indiabulls HF, ONGC (+1%). Losers: Britannia, Axis Bank (-1%).

BNP Paribas sought to sell 5.1% stake in SBI Life Insurance at Rs575 apiece, as per media reports.

MSTC’s shares to start trading on BSE/NSE after IPO gets 146 percent demand at Rs120 a share.

Power Finance Corporation stated that it had acquired a 52.63% stake of share capital of REC, worth Rs14,500cr from the government and became the holding company and the promoter of REC.

Rail Vikas Nigam IPO opens today. The price band is set at Rs17-19 per equity share of face value of Rs10 each of the Company (the equity shares).

Wabco India said that its holding company has entered into a definitive agreement to sell all of its outstanding shares in an all cash transaction at $136.5 per share aggregating to $7bn to ZF Friedrichshafen.
[29/03, 09:24] My Office: Positional Call - Adani Ports | Buy between Rs380-382 | Stoploss Rs377.5 | Target Rs388 | (Holding period 1 - 7 Days).

Stock Future - Siemens | Buy at Rs1095-1100 | Stoploss Rs1075 | Target Rs1117-1120 | (Hold till Expiry).

[28/03, 09:12] My Office: Market view: Nifty finds support at 11,413, while it faces resistance around 11,546. Bank nifty now trades in uncharted territory with 29,900 acting as support & 30,375 acting as resistance.
[28/03, 09:13] My Office: Sheela Foam stock in focus. Promoters said they will exercise the over-subscription offer to sell 9.75 lakh shares or 2% of the total equity capital. OFS was subscribed 2.78 times the demand for the non-retail investors with an indicative price of Rs 1,184.49/share, as per the NSE data.

Strides Pharma Science board approved divestment of Australia Business for transactions up to Rs500c with Solara Active Pharma Sciences in each financial year, starting from the financial year 2019.

Tata Motors’ long term rating downgraded to ‘B+’ from ‘BB-’ by S&P. The ratings remain on watch negative and the agency expects cash flow to remain negative at least for the next 12-18 months before the Chinese operations stabilize and cost cuts restore its financial health, as per media reports.

Mahindra & Mahindra Financial Services increased its stake from 88.75% to 98.43% in Mahindra Rural Housing Finance for Rs286.78cr.

Mcleod Russel completed the sale of its Rwandan arm to Rwanda Tea Investment. The board has accepted the resignation of BM Khaitan as the chairman of the company on account of old age, but he will continue to be ‘Chairman Emeritus’. Existing Vice-Chairman of the Board Aditya Khaitan will be the next Chairman.

NBCC received infrastructure orders worth Rs1,003cr for five development projects across the country.
[28/03, 09:13] My Office: BofAML upgraded to ‘Buy’ from ‘Neutral’ on HCL Technologies, hiked a TP to Rs1,250 from Rs1,060.
Expect organic revenue growth rate to improve in 2019-20.
Poised to gain from the large deal intake, lower portfolio drag.
See stable margin on accretion from software products in the next financial year. 2019-20 revenue guidance implies an uptick in organic growth rate.
BofAML upgraded to ‘Buy’ from ‘Neutral’ on L&T Technologies, hiked price a TP to Rs1,650 from Rs800.

Large projects and leveraging of M&A lift growth visibility.
Maturing sales construct to drive 15% revenue CAGR.
Expect stable margins and better pricing power versus IT.
Deutsche Bank maintained ‘Sell’ on IDFC First Bank; raised a TP to Rs44 from Rs35.
Find the risk-reward extremely unfavourable for the stock.
The focus will be to build CASA - but this will be a long and costly journey.
Very long gestation period to earn its cost of capital.
See subdued RoEs and RoAs by around 8% and 0.7% respectively until 2022-23.
CLSA maintained ‘Buy’ on Godrej Properties, with a TP of Rs1,024.

Record new launches driving share gains for the company.
Launch pace pick-up supported by project pipeline, faster churn.
Strong response to Pune affordable launch indicates good end-user demand.
Source: Media reports
[28/03, 09:27] My Office: Positional Call - Praj Industries | Buy between Rs156-157 | Stoploss Rs155.25 | Target Rs160 | (Holding period 1 - 7 Days).

Stock Future - Dabur | Sell at Rs411-415 | Stoploss Rs421 | Target Rs404-404.5 | (Hold till Expiry).
[28/03, 10:12] My Office: Sensex Up Equity benchmark indices opened higher on Thursday on rally led by Infosys, TCS, HCL Tech, and ITC. The Sensex was up 165 points at 38,298, and the Nifty50 index rose 49 points at 11,494. The market breadth was positive with 1,091 shares advancing, 466 shares declining, and 513 remaining unchanged on the NSE.

In the broader market, the BSE Midcap index was trading 60 points higher at 15,227, while the BSE Smallcap index was ruling at 14,845, up 66 points.

Volatility index India VIX was marginally up 0.48% at 17.13.

The Indian rupee opened 23 paise lower at 69.11 against the US dollar on Thursday amid weak global cues.

On the sectoral front, Nifty IT index surged 2%, with all the companies trading in the green. Realty, media, banking and FMCG stocks were trading higher in the range of 1-2% respectively.

Shares of Strides Pharma were trading slightly lower on the BSE in the morning trade. The company’s shareholders passed a resolution approving the divestment of the company’s Australia business.

HCL Tech, Adani Ports, Infosys, and TCS are trading higher, while ONGC, Dr Reddy’s, and Bharti Airtel are trading lower on the NSE.

The most active stocks on the NSE are Yes Bank, Gruh Finance, Infosys, TCS, and ICICI Prudential.

Meanwhile, Asian markets declined as the precipitous decline in developed-market sovereign bond yields continued to unnerve investors about the economic outlook.
[28/03, 10:13] My Office: Dabur in its filing to the exchanges informed that the company will dissolve its step down wholly owned subsidiary "Dabur Tunisie" by December 2019 instead of March 2019 as informed earlier.

The extension in dissolve period is due to certain legal and regulatory compliances under the law of Tunisia, the company said in a press note after markets hours to the exchanges on Wednesday.

However, the company did not disclose the reason for dissolve process.

Dabur India Ltd's share price ended at Rs412.25, down by Rs12.3 or 2.9%, from its previous close of Rs424.55 on the BSE.

The scrip opened at Rs428.95 and touched a high and low of Rs428.95 and Rs410, respectively. A total of, 52,55,638 (NSE+BSE) shares have traded on the counter. The current market cap of the company is Rs72,815.35cr.

Opening Bell: Gainers: IOC, Yes Bank (+1.5%), Airtel (+1%). Losers: UltraTech, NTPC (-1%).

L&T’s open offer to buy 31% shares in Mindtree will commence on May 14 and close on May 27, the company said in a detailed public statement (DPS) on March 26.

Mindtree board has decided not to proceed with a buyback of equity shares of the company and has formed directors panel to evaluate L&T open offer.

Sheela Foam stock in focus as it two promoters to sell up to 8.68% stake in the company via offer for sale on March 27-28. OFS floor price set at Rs1,100 per share.

Ireland’s HMPRA and the UK’s MHRA carried out a joint inspection of Wockhardt’s Aurangabad facility. The company said that HPRA has granted GMP certificate for the aforementioned facility for a period of three years until January 2022.

Allahabad Bank’s board approved raising equity up to Rs4,000cr provided the stake of the government of India remained not less than 52% of the total equity paid up capital of the bank.

Dr. Reddy’s Laboratories' Allant Grant Oberman appointed as Independent (Additional) Director for five years with effect from March 26.

RBI imposed an Rs2cr penalty on Punjab National Bank during the assessment of the implementation of SWIFT-related operational controls.

Trading Strategy
Dr. Reddy's Laboratories (Buy at `2748-2756, Target `2802, Stop Loss `2726.65): The stock has been consolidating for the past four weeks and has finally broken out from a consolidation pattern on the daily chart. The price outburst has been accompanied with smart uptick in traded volumes. Dr. Reddy's has also held firmly above its 50-DEMA. Hold long positions with mentioned stop loss on closing basis.
Derivative Strategy (Time period: Till expiry)
BUY Sun Pharma March future at `474-477, Stop Loss `466.75 and Target `485.5-486.
Nifty Outlook: Nifty finds support around 11480, while it faces resistance around 11630. Bank Nifty finds support around 29600, while it faces resistance around 30000.
Asian markets opened mixed with the Japanese Nikkei trading flat to mildly negative as profit booking emerged in early trade. Expect more color as other Asian indices trade positive with most awaiting more news from the US/China trade talks to fructify. Fall in US bond yields bodes well for Asian markets as money chases high beta returns in emerging markets.
Derivative Snippets
Nifty/Bank Nifty Weekly expiry update:  On the options front (March 28, 2018 expiry), Nifty traded in a narrow range throughout the day propelling option writers to create short vega positions in out of the money call and put option strikes.
 Bank Nifty continued to add fresh open interest, consisting of mainly long positions.  India Vix ends the session 3% lower at 16.03.  FIIs were net buyers in the cash market segment to the tune of `1,772cr.
FII Long-Short Activity Index OI % Chg % Chg Since Exp Long-Short

Goldman Sachs upgrades India to 'overweight' sees Nifty moving to 12,500....
Sachs expects earnings to grow 16 percent this year, highest in the region

all of you agree with this ??????

CPSE ETF 4th Series

Date:
20-03-2019 to 22-03-2019

Application Amount:
Min:5000 Max:2lakh

Issue offer:3500cr+6500cr Green Shoe

Cheque Name :
"CPSE ETF FFO-4"

Recommend to Apply for long term.

Trading Strategy
Oriental Bank of Commerce (Buy at `103-104,
Target `105.5, Stop Loss `102.3): The stock
has been trending very strongly in the past four
weeks and has also formed a solid bullish
candle stick pattern on the daily chart. The
relative strength index hovers above the 70
mark indicating strong momentum in the
current upmove. It has also breached past its
weekly 100-WEMA. Hold long positions with
mentioned stop loss on closing basis.
Derivative Strategy (Time period: Till expiry)
Buy Engineers India March future at `114.5-115,
Stop Loss `112.5 and Target `117-117.5.
Nifty Outlook: Nifty finds support around 11412,
while 11530 will act as resistance. Bank Nifty
finds support around 29350, while 29850 will act
as resistance on the upside.
Asian markets opened mixed with the Japanese
Nikkei trading marginally in the red even as most
other indices traded positive. The up move in
Chinese stocks continues with the Shanghai index
up over 31% from the December lows. For today,
expect consolidation as markets await the
Federal Reserve's direction on rates going
forward.
March 19, 2019
Derivative Snippets
Nifty/Bank Nifty Weekly expiry update:
 On the options front, (March 20, 2018 expiry
the trend of an unwinding of open positions
in index call options continued at across the
board short covering was witnessed in both
Nifty and Bank Nifty ITM Call options while
put option strikes continued to add fresh
short positions as indices trend higher.
 Nifty & Bank Nifty continued to add fresh
open interest, consisting of mainly long
positions.
 India Vix ends the session 7% higher at 16.9.
 FIIs were net buyers in the cash market
segment to the tune of `1823cr.

भारतीय राजनीति के सबसे सरल व्यक्तित्व
पूर्व रक्षा मंत्री और गोवा के मुख्यमंत्री श्री मनोहर पर्रिकर जी को शत शत नमन
ॐ शांति शांती शांति:

आपकी पुण्यात्मा को ईश्वर अपने श्रीचरणों में स्थान दें यही ईश्वर से प्रार्थना है 🙏🙏